ZARR

News and price dashboard

Swept 15:50
Sources
27, all reachable
Items
108353
Flagged
13151
Last swept
15:50

STOCKS

121

OPTIONS

25

COMING UP

US majors and your names' earnings, next 7 days

Full calendar

Everything else — unscored, browse only, never pushed

Brief

What this feed is today

The general feed is dominated by Q3 2026 earnings-reaction pieces from Investing.com, a long run of Trump Truth Social election endorsements on US midterm day, routine SEC form filings, and a thick layer of TradingView chart commentary. Twenty items were read in full; nine of those are single-stock "why is X moving" explainers, and they carry nearly all the substance here. All the percentage moves below are pre-market figures quoted inside those articles, not live quotes.

Biggest earnings reactions, Ibotta and Madrigal

Ibotta was the largest mover read in full, up 15.8% pre-open after Monday-night Q3 results: revenue up 17% year over year to $97.8 million and adjusted EBITDA up 43% to $23.8 million, a 24.3% margin, the fourth straight quarter above the top of its own guidance. Redeemers hit a record 23.6 million, up 30% year over year, and third-party publisher redemption revenue rose 43% to $70.7 million. CEO Bryan Leach pointed to accelerating revenue growth. Needham took its target to $65 from $45, Evercore ISI to $58 from $42, and Goldman Sachs upgraded from Sell to Neutral with a $58 target from $35, citing traction in the platform transition. Q4 revenue guidance was $94–98 million. Madrigal Pharmaceuticals was close behind at 14.1%, reaching $491.90, after posting adjusted EPS of $1.83 against an expected loss of $0.83, and revenue of $431.3 million versus roughly $405.3 million consensus, up 50% year over year. All of that revenue was Rezdiffra, the MASH drug, which crossed $1.1 billion year-to-date in under three years from launch, with more than 55,850 patients on therapy as of September 30, nearly double a year earlier. The company also announced a MAESTRO-CSPH outcomes trial in well-compensated MASH cirrhosis. A separate headline notes Madrigal beat by $2.66.

Revvity, Graphic Packaging and other upside beats

Revvity rose 8.8% pre-open on adjusted EPS of $1.37 against $1.30 consensus and revenue of $729 million versus $694.72 million, about 10% growth, with Life Sciences pro forma revenue up 11% and operating margin at 13.1% from 11.7%. Full-year guidance went to $5.40–5.45 pro forma adjusted EPS on roughly $2.86 billion revenue, and an Investor Day is set for November 13. Graphic Packaging jumped 8.7% on adjusted EPS of $0.23, in line, with revenue of $2.19 billion against $2.17 billion expected; the bigger lever was reaffirmed full-year adjusted cash flow of $600–700 million against $169 million in 2025, a revenue outlook lifted to about $8.6 billion, a second straight quarter of sequential EBITDA margin expansion, and net debt down to $5.18 billion from $5.33 billion. The article stresses the stock had been near its 52-week low of $8.15 with a consensus "Reduce" rating, so short-covering likely amplified the move to $10.14. Cinemark gained 3.9% on EPS of $1.04 against $0.89 and revenue of $1.06 billion against $1 billion, its best-ever Q3, with 63.7 million attendees and adjusted EBITDA margin up 460 basis points to 25.3%; Morgan Stanley had raised its target to $45 from $40 the prior day while staying equal-weight. Yum! Brands rose 3.6% on adjusted EPS of $1.56 against $1.53, with the Pizza Hut divestiture completed for an approximately $1.7 billion pre-tax gain that pushed GAAP EPS to $5.92. KFC opened 955 gross new units with 6% system sales growth, digital system sales passed $9 billion at a 64% mix, and CEO Chris Turner said Taco Bell US has been outpacing the industry on same-store sales since end-September after a 4% Q3 decline tied to a multistate cyclospora outbreak.

The two decliners read in full

Gartner fell 6.5% despite beating on both lines, with adjusted EPS of $3.59 against $2.84 and revenue of $1.5 billion, which was still down 1.3% year over year. The article's point is that the EPS beat leaned heavily on buybacks: diluted share count was 63.9 million versus 75.0 million a year earlier. CEO Gene Hall said contract value growth accelerated again and raised full-year guidance across revenue, adjusted EBITDA, adjusted EPS and free cash flow, with FX-neutral contract value of $5.3 billion, up 2.5%. Against a roughly 27% three-month run-up and $1.17 million of insider sales over 90 days, the reaction was a sell-the-news. Clarivate slid 5.4%: adjusted EPS of $0.21 beat the $0.18 consensus but continuing-operations revenue of $481.6 million came in about 16.7% below the $566.77 million estimate and down 9.2% year over year, mostly from disposals. Full-year revenue guidance of $1.96–1.98 billion sits well under the roughly $2.20 billion consensus. The Life Sciences & Healthcare divestiture closed October 6 for $488.4 million net cash, which reset the revenue base.

Bloom Energy and the carbon capture MOU

Bloom Energy was up 6.3% pre-open on a non-binding memorandum of understanding with California Resources Corp and its Carbon TerraVault subsidiary to evaluate 1 gigawatt or more of solid-oxide fuel cell generation paired with carbon capture and storage in California, with Carbon TerraVault handling CO2 transport and storage and likely power buyers including utilities, municipalities and data centers. Barclays upgraded to Overweight with a $289 target the same day, after a roughly 31% drop over the prior month; Oppenheimer stayed at Perform and flagged that the MOU is non-binding with no financial commitments. A Form 144 on November 2 flagged a possible insider sale. The company is also presenting at DCD Connect Virginia on November 3–4 on onsite power for data centers.

The macro backdrop these articles describe

Several of the full-text pieces share the same framing: a flat-to-soft US tape with the S&P 500 roughly unchanged, the Dow slightly lower and the Nasdaq marginally positive, so each of these moves was company-specific. The Gartner piece adds the most macro colour, citing Apple's quarterly report, the US midterm elections underway, pressure on global tech, questions over returns on data center and AI infrastructure spending, and elevated Treasury yields weighing on long-duration earnings.

Headline-only clusters

The rest is breadth without depth. A long list of earnings headlines runs both ways: beats on EPS with revenue misses at HNI, Hamilton Lane, Arvinas, ADT and Yum! Brands; misses at Chegg, Angel Oak Mortgage, Beam, Willis Lease and XPLR Infra; beats on both lines at Teva, Rhythm, IPG Photonics and Alkermes; Fiserv and Shopify beating EPS with in-line revenue. Shopify, Zebra Technologies, Keurig Dr Pepper and Yum China have "sliding/tumbling" explainers I did not read, and Investor's Business Daily headlines Shopify's plunge on gross operating profit and revenue. DigitalOcean is headlined as falling 8% despite a beat and raised guidance, while Talen Energy, HNI and Regal Rexnord are each headlined up around 2–3%. Other one-liners worth knowing exist: Anthropic reportedly targeting a doubling of compute to 7 gigawatts next year per the NYT, Marathon beating estimates and selling two refineries to CVR Energy, Pfizer raising guidance and naming a new CFO, ADNOC Gas signing a five-year LNG supply deal with TotalEnergies, Sysco naming Brandon Sewell CFO, and CACI winning a $108 million Air Force contract. There is also a stack of Form 8K and Form 4 filing notices with no content behind the headline, and a large volume of TradingView chart posts on gold, silver, bitcoin, US30 and individual names, none of which carry reported news.

Trump endorsement posts

Seven Truth Social posts were read in full and several more appear as headlines. They are all the same template, posted November 3 around 7:20 a.m. EST on midterm election day: endorsements of Abe Hamadeh (AZ-8), Brad Finstad (MN-1), Monica De La Cruz (TX-15), Nick Begich (AK), Paul LePage (ME-2), Bill Huizenga (MI-4) and Tom Barrett (MI-7), each naming the Democratic opponent and repeating the same attack lines about no tax on tips, overtime and Social Security. The only item with any market-adjacent content is the Hamadeh post, which claims a record $300 billion newly invested in Arizona under his administration to build what he calls the biggest chip and semiconductor plant in the world. Headline-only versions cover Clay Higgins, David Flippo, Anthony Constantino, Aaron Flint and Ralph Alvarado.

20 read in full, 200 items in the section

Feed

146 stories · 146 newCross-publisher stories only
  1. Pinned
  2. 146 new
  3. StubHub stock may move 14% on Nov. 10 earnings release
    Investing.com - news 3 itemsalso Investing.com - UK, Investing.com - news
  4. Freshworks earnings on deck: Can growth sustain after strong Q2?
    Investing.com - news 2 itemsalso Investing.com - UK
  5. Earnings call transcript: New Mountain Finance posts flat Q3 2026 EPS
    Investing.com - news 2 itemsalso Investing.com - UK
  6. Acushnet earnings up next as investors eye product launch timing
    Investing.com - news 2 itemsalso Investing.com - UK
  7. Roku stock hits 52-week high at 160.23 USD
    Investing.com - UK 23 itemsalso Investing.com - news